The granting of emergency use authorization by the U.S. FDA to Roche AG for its four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and respiratory syncytial virus will allow the company to quickly bring the test to near-patient care environments ahead of the flu season, to address a real need in the marketplace, Ian Parfrement, head of the point of care customer area, at Roche Diagnostics, told BioWorld.
If you know a fleet or risk manager whose leadership and innovation have enhanced the safety of fleet drivers and their organizations, consider nominating them or yourself for the annual Fleet Safety Award!
Press release - AMA Research & Media LLP - Antibody Discovery Market Demand Will Increase to 2030 Evaluated By Global Top Players Like BASF SE., Bruker, Alcami - published on openPR.com
OncLive's May Roundup of Key FDA Approvals in Oncology onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.